Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy
Background In recent studies of cancer therapies, chemodrugs have attracted interest,
acting not only as traditional chemotherapeutic agents but also as anticancer immune …
acting not only as traditional chemotherapeutic agents but also as anticancer immune …
Therapeutic and diagnostic applications of carbon nanotubes in cancer: recent advances and challenges
M Sharma, P Alessandro… - Journal of Drug …, 2024 - Taylor & Francis
Carbon nanotubes (CNTs) are allotropes of carbon, composed of carbon atoms forming a
tube-like structure. Their high surface area, chemical stability, and rich electronic …
tube-like structure. Their high surface area, chemical stability, and rich electronic …
An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER …
CY Li, TF Chou, YL Lo - International Journal of Biological Macromolecules, 2024 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a significant obstacle to lowering global
cancer deaths. CB-5083, a novel valosin-containing protein (VCP)/p97 inhibitor that disrupts …
cancer deaths. CB-5083, a novel valosin-containing protein (VCP)/p97 inhibitor that disrupts …
Nitric oxide water-driven immunogenic cell death: Unfolding mitochondrial dysfunction's role in sensitizing lung adenocarcinoma to ferroptosis and autophagic cell …
Non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma (LUAD), significantly
influences cancer-related mortality and is frequently considered by poor therapeutic …
influences cancer-related mortality and is frequently considered by poor therapeutic …
Durable Attenuation of Tumor pH–Platelet Linkage Reinstates Bioorthogonal Targeting of Residual Tumors Post-Debulking
P Zhang, B Li, Z Wang, J Li, F Wang, J Kong, Z Zhou… - ACS …, 2024 - ACS Publications
There are circumstances where tumors can only be partially resected. Therefore,
multimodality therapy targeting post-operative residuals is important. Here, we show that …
multimodality therapy targeting post-operative residuals is important. Here, we show that …
Bioinspired adhesive nanofibrous hydrogel promotes immune infiltration through effective immunochemotherapy for osteosarcoma treatment
CH Lee, WY Huang, KY Lee, CH Kuan, TC Wu… - Chemical Engineering …, 2024 - Elsevier
Osteosarcoma, the predominant primary malignant bone tumor, presents ongoing clinical
challenges, notably in local recurrence and metastasis. Here, we introduce a nanofibrous …
challenges, notably in local recurrence and metastasis. Here, we introduce a nanofibrous …
Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy
CW Song, H Kim, MS Kim, HJ Park, SH Paek… - Cancer Research and …, 2024 - e-crt.org
Tumor microenvironment is intrinsically hypoxic with abundant hypoxia-inducible factors-1α
(HIF-1α), a primary regulator of the cellular response to hypoxia and various stresses …
(HIF-1α), a primary regulator of the cellular response to hypoxia and various stresses …